Polynovo logo

PNV - Polynovo Share Price

A$2.45 0.1  2.1%

Last Trade - 17/01/20

Sector
Healthcare
Size
Mid Cap
Market Cap £854.4m
Enterprise Value £847.1m
Revenue £7.22m
Position in Universe 205th / 1833
Bullish
Bearish
Unlock PNV Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PNV Revenue Unlock PNV Revenue

Net Income

PNV Net Income Unlock PNV Revenue

Normalised EPS

PNV Normalised EPS Unlock PNV Revenue

PE Ratio Range

PNV PE Ratio Range Unlock PNV Revenue

Dividend Yield Range

PNV Dividend Yield Range Unlock PNV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
PNV EPS Forecasts Unlock PNV Revenue
Profile Summary

PolyNovo Limited is a medical device company. The Company designs, develops and manufactures solutions for standalone and combination devices using its NovoSorb biodegradable polymer technology. The Company focuses on medical devices that are used in the treatment of burns, surgical wounds and negative pressure wound therapy (NPWT). It is involved in the development of NovoPore for use as a dressing in NPWT that involves a wound-contacting foam dressing, a sealing membrane, a suction pump, and a drainage tube from the dressing to a canister, and Biodegradable Temporising Matrix (BTM), a wound dressing focused on treatment of full-thickness wounds and burns where the dermal structure has been lost to trauma, or damaged requiring surgical removal, and requires a split-thickness skin graft for final closure. In addition, the Company is engaged in the development of breast sling prototypes for non-clinical and clinical trials, as well as new products for hernia and breast reconstructions.

Directors
Last Annual June 30th, 2019
Last Interim June 30th, 2019
Incorporated August 12, 1998
Public Since November 26, 1998
No. of Shareholders: 10,313
No. of Employees: 47
Sector Healthcare
Industry Biotechnology & Medical Research
Index S&P/ASX All Ordinaries , S&P/ASX 200 , S&P/ASX 300 , ASX Small Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 661,088,044
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PNV Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PNV
Upcoming Events for PNV
Similar to PNV
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.